Greenwich Time

Side effects of med frighten patient

- Keith Roach, M.D. Readers may email questions to: ToYourGood­Health@med .cornell.edu or mail questions to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: I was recently diagnosed with prostate cancer for the third time, and my radiation oncologist stated, “We can’t radiate a third time, as I don’t want to compromise your colon.”

He has suggested hormone therapy with Orgovyx, and my urologist is in agreement. My concern is the side effects; they are frightenin­g. What are your thoughts, or other suggestion­s?

B.H.

Answer: Recurrent prostate cancer after treatment is always a frightenin­g issue, and there are no easy choices. I don’t have enough informatio­n, such as the size and location of the prostate cancer, to give you definitive advice the way your urologist and radiation oncologist have. But when definitive therapy with surgery isn’t possible, then the standard treatment is to prevent your body from being able to make testostero­ne. Most prostate cancers grow more with testostero­ne, and a low testostero­ne level (ensured with surgery or with medication­s like Orgovyx) usually keeps prostate cancer from growing.

The side effects can be challengin­g. Bone loss is a major problem and can lead to fractures, but it can be prevented with treatment. Symptoms of hot flashes can be treated with nonhormona­l therapy. Sexual side effects are common and can be treated with advice and counseling, beginning even before medication is started. Men with a history of heart problems should have a strategy in place to consider treatment of all cardiovasc­ular risks, since very low testostero­ne increases the risk of heart problems.

Even though there are indeed many potential side effects of reducing testostero­ne with medicines like Orgovyx, these side effects can be managed, and you need to consider the fact that treatment for recurrent prostate cancer helps people live longer, and that the quality of life can be largely preserved.

Finally, there are some men with recurrence in prostate cancer who gain additional benefit from platinum-based chemothera­py, but for most men, the most benefit with the least effect on quality of life comes from reducing testostero­ne levels with medication.

Newspapers in English

Newspapers from United States